Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads

Inhibitory Smads, i.e. Smad6 and Smad7, are potent antagonists of the BMP–Smad pathway by interacting with activated bone morphogenetic protein (BMP) type I receptors and thereby preventing the activation of receptor-regulated Smads, or by competing with activated R-Smads for heteromeric complex for...

Full beskrivning

Bibliografiska uppgifter

I publikationen:	EMBO J
Huvudupphov:	Itoh, Fumiko, Asao, Hironobu, Sugamura, Kazuo, Heldin, Carl-Henrik, ten Dijke, Peter, Itoh, Susumu
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Nature Publishing Group 2001
Ämnen:	Article
Länkar:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149146/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11483516/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/emboj/20.15.4132
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!